Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury
- PMID: 24715976
- PMCID: PMC3954172
- DOI: 10.12688/f1000research.3-28.v2
Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury
Abstract
Oxidative stress is a proposed mechanism in brain aging, making the study of its regulatory processes an important aspect of current neurobiological research. In this regard, the role of the aging regulator insulin-like growth factor I (IGF-I) in brain responses to oxidative stress remains elusive as both beneficial and detrimental actions have been ascribed to this growth factor. Because astrocytes protect neurons against oxidative injury, we explored whether IGF-I participates in astrocyte neuroprotection and found that blockade of the IGF-I receptor in astrocytes abrogated their rescuing effect on neurons. We found that IGF-I directly protects astrocytes against oxidative stress (H 2O 2). Indeed, in astrocytes but not in neurons, IGF-I decreases the pro-oxidant protein thioredoxin-interacting protein 1 and normalizes the levels of reactive oxygen species. Furthermore, IGF-I cooperates with trophic signals produced by astrocytes in response to H 2O 2 such as stem cell factor (SCF) to protect neurons against oxidative insult. After stroke, a condition associated with brain aging where oxidative injury affects peri-infarcted regions, a simultaneous increase in SCF and IGF-I expression was found in the cortex, suggesting that a similar cooperative response takes place in vivo. Cell-specific modulation by IGF-I of brain responses to oxidative stress may contribute in clarifying the role of IGF-I in brain aging.
Conflict of interest statement
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0000.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0001.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0002.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0003.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0004.gif)
![Figure 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0005.gif)
![Figure 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0006.gif)
![Figure 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4244765/bin/f1000research-3-4206-g0007.gif)
Similar articles
-
Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity.J Biol Chem. 2016 Jan 29;291(5):2510-23. doi: 10.1074/jbc.M115.695478. Epub 2015 Dec 2. J Biol Chem. 2016. Retraction in: J Biol Chem. 2016 Jun 3;291(23):12039. doi: 10.1074/jbc.A115.695478. PMID: 26631726 Free PMC article. Retracted.
-
Insulin-Like Growth Factor-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit.Front Aging Neurosci. 2021 Nov 23;13:751304. doi: 10.3389/fnagi.2021.751304. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34887742 Free PMC article.
-
Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain.J Neurosci. 2020 Sep 16;40(38):7355-7374. doi: 10.1523/JNEUROSCI.0115-20.2020. Epub 2020 Aug 19. J Neurosci. 2020. PMID: 32817249 Free PMC article.
-
Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.Brain Res Brain Res Rev. 2001 Nov;37(1-3):320-34. doi: 10.1016/s0165-0173(01)00137-0. Brain Res Brain Res Rev. 2001. PMID: 11744097 Review.
-
Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.ScientificWorldJournal. 2006 Jan 18;6:53-80. doi: 10.1100/tsw.2006.22. ScientificWorldJournal. 2006. PMID: 16432628 Free PMC article. Review.
Cited by
-
The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states.Mol Psychiatry. 2023 Aug;28(8):3220-3230. doi: 10.1038/s41380-023-02136-6. Epub 2023 Jun 23. Mol Psychiatry. 2023. PMID: 37353586 Review.
-
CTLA4-Ig protects tacrolimus-induced oxidative stress via inhibiting the AKT/FOXO3 signaling pathway in rats.Korean J Intern Med. 2023 May;38(3):393-405. doi: 10.3904/kjim.2022.293. Epub 2023 Apr 28. Korean J Intern Med. 2023. PMID: 37157174 Free PMC article.
-
Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction.CNS Neurosci Ther. 2023 Sep;29(9):2481-2497. doi: 10.1111/cns.14190. Epub 2023 Mar 27. CNS Neurosci Ther. 2023. PMID: 36971196 Free PMC article.
-
Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome.Cell Biosci. 2023 Jan 23;13(1):16. doi: 10.1186/s13578-023-00966-z. Cell Biosci. 2023. PMID: 36691085 Free PMC article. Review.
-
Exosome-transported lncRNA H19 regulates insulin-like growth factor-1 via the H19/let-7a/insulin-like growth factor-1 receptor axis in ischemic stroke.Neural Regen Res. 2023 Jun;18(6):1316-1320. doi: 10.4103/1673-5374.357901. Neural Regen Res. 2023. PMID: 36453417 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials